Brief: Cns Pharma Announces Collaboration With European Partner To Expand Trials To Pediatric Brain Tumors
11/02/2020 13:30
Feb 11 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS ANNOUNCES COLLABORATION WITH EUROPEAN
PARTNER TO EXPAND CLINICAL TRIALS TO PEDIATRIC BRAIN TUMORS
* CNS PHARMACEUTICALS ANNOUNCES COLLABORATION WITH EUROPEAN
PARTNER TO EXPAND CLINICAL TRIALS TO PEDIATRIC BRAIN TUMORS
Source text for Eikon: ID:nPn1dKm3La
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WPD Pharmaceuticals
See all newsBrief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech